Vincent A. Forlenza – Chairman and Chief Executive Officer of Becton, Dickinson and Company – Email Address

Vincent A. Forlenza, also known as Vince, has been the Chairman of Becton, Dickinson and Company since July 1, 2012 and has been its President since January 1, 2009 also Chief Executive Officer since October 1, 2011. Mr. Forlenza oversees Becton, Dickinson and Company's three business segments (BD Medical, BD Diagnostics and BD Biosciences), International and the Quality function. He served as the Chief Operating Officer of Becton, Dickinson and Company from July 29, 2010 to October 1, 2011. He served as an Executive Vice President of Becton, Dickinson and Company from June 2006 to January 1, 2009. Mr. Forlenza joined Becton, Dickinson and Company in 1980 and Mr. Forlenza held leadership positions of increasing responsibility in the United States and Europe. He served as Senior Vice President of Technology, Strategy and Development of Becton, Dickinson and Company. He served as President of BD Biosciences and Executive Vice President and President of BD Diagnostics. Mr. Forlenza was instrumental in the early development of two significant new infectious disease diagnostics systems, BD ProbeTec (TM) ET and BD Phoenix (TM). Mr. Forlenza is active in various professional and community associations. He serves as Chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors. He served as the Chairman of AdvaMedDx at Advanced Medical Technology Association since October 2010. As AdvaMedDx chair, Forlenza oversaw significant growth of the division and helped establish AdvaMedDx as the leading advocate for the value of diagnostics. Mr. Forlenza serves on the Board of Trustees of The Valley Hospital at The Valley Health Systems and previously served as Chairman of The Valley Hospital. He is a Member of the Advisory Board for the P.C. Rossin College of Engineering and Applied Sciences at Lehigh University. He has been a Director at Becton, Dickinson and Company since October 1, 2011. Mr. Forlenza obtained his BS in chemical engineering from Lehigh University in 1975 and his MBA

Becton, Dickinson and Company (BD) is an American medical technology company that manufactures and sells medical devices, instrument systems and reagents. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 people in more than 50 countries throughout the world.[2] In fiscal year ending September 30, 2009, 60% of BD sales were generated from non-U.S. markets.

The company's customers include healthcare institutions, science researchers, clinical laboratories, the pharmaceutical industry and the general public. BD was one of the first companies to sell U.S.-made glass syringes. It was also a pioneer in the production of hypodermic needles. Today, BD is divided into three segments: BD Medical, BD Diagnostics and BD Biosciences.[3] BD is ranked #336 in the 2014 Fortune 500 list.[4]

Comments are closed.